ESLAW

ESLAW represents warrants issued by Estrella Immunopharma, Inc., providing holders with the right to purchase shares of ESLA common stock at a specified exercise price within a defined time period. These derivative securities offer leveraged exposure to the company's clinical development progress and potential commercial success. The warrants trade independently from the underlying common stock and may have been issued as part of financing transactions or unit offerings. Warrant value fluctuates based on ESLA's stock price relative to the exercise price, remaining time until expiration, and perceived probability of successful drug development.